Thu, Jul 24, 2014, 2:59 PM EDT - U.S. Markets close in 1 hr 1 min

Recent

% | $
Click the to save as a favorite.

EntreMed, Inc. Message Board

  • semiequipmentgodoftheyear semiequipmentgodoftheyear Oct 29, 2006 12:34 AM Flag

    Royalty Payment $7.3 million for CY 06,

    MY GUESS, IS THE MINIMUM NUMBER!

    FROM ENMD'S 2005 REPORT:

    annual Thalomid� sales above a certain threshold. Based on the licensing agreement royalty formula, annual royalty sharing commences with Thalomid� annual sales of approximately $225 million.

    2005 Royalty Revenues $5.3 million



    CURRENT CELG RESULTS:

    Summit, New Jersey-based Celgene said sales of Thalomid, a treatment for multiple myeloma, rose 9.3 percent to $108.4 million

    THALOMID� sales for the nine-month period of 2006 were $322.8 million compared to $282.0 million in 2005, an increase of 14.5% year-over-year.

 
ENMD
1.71+0.03(+1.79%)Jun 13 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.